OMEGA Study: Design, Baseline Data, Metabolic Syndrome Prevalence in a Large-Scale Observational Study of Hypertensive Patients: The Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement Study-Reference-Cited by-同舟云学术

OMEGA Study: Design, Baseline Data, Metabolic Syndrome Prevalence in a Large-Scale Observational Study of Hypertensive Patients: The Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement Study

Published:2008-11 Issue:11 Volume:31 Page:2011-2017
ISSN:0916-9636
Container-title:Hypertension Research
language:
Short-container-title:Hypertens Res

Author:

Teramoto Tamio,Fujita Toshiro,Kawamori Ryuzo,Miyazaki Shigeru,Teramukai Satoshi,Igarashi Masao

Publisher

Japanese Society of Hypertension

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference32 articles.

1. 1. Committee to Evaluate Diagnostic Standards for Metabolic Syndrome: Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 2005; 94: 794-809 (in Japanese).

2. Metabolic Syndrome - Definition and Diagnostic Criteria in Japan

3. Diagnosis and Management of the Metabolic Syndrome

4. 4. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K: Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in non-diabetic European men and women. Arch Intern Med 2004; 164: 1066-1076.

5. Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uncovering Adiponectin Replenishing Property of Sujiaonori Algal Biomaterial in Humans;Marine Drugs;2017-02-08

2. Dynamic prediction model and risk assessment chart for cardiovascular disease based on on-treatment blood pressure and baseline risk factors;Hypertension Research;2015-11-26

3. Lipid and Blood Pressure Control for the Prevention of Cardiovascular Disease in Hypertensive Patients: A Subanalysis of the OMEGA Study;Journal of Atherosclerosis and Thrombosis;2015

4. RETRACTED: Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation;European Journal of Pharmaceutical Sciences;2014-01

5. Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study risk factor sub-analysis;Clinical and Experimental Hypertension;2013-07-18